Axonics (AXNX US): Large Underserved Market And Superior Portfolio Ensure Multi-Year Growth
Axonics predicts the U.S. sacral neuromodulation market will double to $1.6B in the next five years. The company is reporting strong revenue...
415 Views
Weekly Stock Bullfinder - Week of 5/15
One of the lasting legacies of the COVID-19 pandemic was the acceleration of secular trends which were already in place prior to the start pandemic...
231 Views
Weekly Stock Bullfinder - Week of 5/1
When considering future investment opportunities, the renewable energy transition continues to be an exciting space to investors given its enormous...
286 Views
Weekly Stock Bullfinder - Week of 2/6
According to BeSpoke investment firm research, the top 10% of the most heavily shorted stocks are up an average of 36.3% so far this year.
287 Views